BioNexus Gene Lab Corp (NASDAQ: BGLC) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BIONEXUS GENE LAB CORP

BioNexus Gene Lab Corp (NASDAQ: BGLC)
Listen to this Section


$2.14
-0.1550 ( -6.75% ) 3.8K

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

Market Data


Open $2.14
Previous Close $2.30
Volume 3.8K
Market Cap $5.51M
Day Range $2.14 - $2.31
52 Week Range $1.92 - $15.60
Shares Outstanding 2.42M
Change % -6.75%
Net Change ▼ -0.1550
Insider Ownership N/A
Exchange NASDAQ
SectorHealthcare
IndustryMedical Specialities
IPO Year2020
CountryMalaysia
UnderwriterNetwork 1 Financial Securities, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Nov 13, 2025
8-k 8K-related 16 Nov 12, 2025
s-3 Registration statements 28 Nov 07, 2025
8-k 8K-related 15 Oct 23, 2025
10-q Quarterly Reports 80 Aug 18, 2025
nt Quarterly Reports 1 Aug 14, 2025
8-k 8K-related 15 Jul 30, 2025
8-k 8K-related 16 Jun 23, 2025

Latest News


× Before browsing our site, please accept our cookies policy